月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE(每份年报一根整柱,柱宽 = 生效期:报告期 + 4 个月起)
加载中…
获利能力 Profitability (单位:美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | 14.95% | -16.10% | 74.67% | 36.96% | 1.52% | 11.52% | 11.47% | 8.57% | 24.22% | 9.52% | 9.25% | 6.43% | 20.38% | 37.42% | 27.59% | 41.10% | 34.50% | 0.87% | 40.81% | 36.91% | 19.95% | -11.79% |
| 总资产收益率(ROA) | 6.58% | -5.46% | 27.77% | 11.47% | 0.81% | 5.97% | 5.81% | 4.17% | 12.14% | 4.37% | 4.11% | 2.72% | 7.53% | 11.66% | 7.72% | 12.35% | 13.30% | 0.34% | 14.62% | 13.34% | 8.09% | -4.30% |
| 毛利率 | 65.10% | 65.29% | 76.59% | 67.12% | 60.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 64.75% | 67.82% | 68.06% | 69.29% | 67.20% | 72.02% | 70.63% | 73.17% | 76.32% | 74.80% | 77.74% | 73.89% |
| 净利率 | 10.79% | -11.61% | 33.26% | 47.48% | 2.14% | 13.30% | 13.33% | 10.26% | 28.25% | 11.29% | 9.90% | 6.03% | 14.64% | 24.95% | 17.03% | 26.82% | 24.50% | 0.63% | 26.70% | 28.09% | 30.36% | -16.96% |
| 每股收益(EPS) | 0.71 | -1.04 | 3.65 | 5.67 | 0.28 | 2.04 | 2.03 | 1.49 | 4.12 | 1.58 | 1.42 | 0.88 | 2.34 | 3.84 | 2.79 | 5.16 | 5.73 | 0.14 | 6.76 | 7.30 | 3.78 | -2.26 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 16.59% | 7.82% | 12.00% | 8.28% | 10.30% | 12.87% | 12.67% | 14.79% | 7.58% | 8.38% | 6.83% | 6.93% | 9.64% | 11.46% | 8.79% | 7.66% | 11.63% | 6.41% | 11.31% | 10.64% | 6.81% | 5.28% |
| 负债占总资产比率 | 50.79% | 64.38% | 62.55% | 45.13% | 46.30% | 45.83% | 47.74% | 50.47% | 50.30% | 55.97% | 57.74% | 60.66% | 67.47% | 69.19% | 72.26% | 63.80% | 57.81% | 64.72% | 60.40% | 61.52% | 58.25% | 67.66% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 5.87 | 4.47 | 8.47 | 4.15 | 6.26 | 5.82 | 6.16 | 6.13 | 6.37 | 6.09 | 5.67 | 5.84 | 5.98 | 5.77 | 6.10 | 5.28 | 6.27 | 5.81 | 6.24 | 5.52 | 2.65 | 2.62 |
| 平均收现日数 | 62 天 | 82 天 | 43 天 | 88 天 | 58 天 | 63 天 | 59 天 | 60 天 | 57 天 | 60 天 | 64 天 | 63 天 | 61 天 | 63 天 | 60 天 | 69 天 | 58 天 | 63 天 | 58 天 | 66 天 | 138 天 | 139 天 |
| 固定资产周转率(次) | 0.6911 | 0.8159 | 0.4377 | 0.6657 | 0.3715 | 0.3392 | 0.6428 | 0.6980 | 0.6902 | 0.6688 | 0.6404 | 0.6574 | 0.6130 | 0.7000 | 0.6710 | 0.5987 | 0.5098 | 0.5499 | 0.5447 | 0.3894 | 0.8054 | 0.7824 |
| 总资产周转率 | 65.92% | 43.52% | 84.83% | 24.39% | 43.47% | 45.70% | 44.54% | 41.68% | 43.03% | 38.85% | 41.74% | 45.66% | 51.18% | 46.35% | 45.33% | 46.08% | 54.31% | 56.35% | 54.79% | 47.50% | 26.66% | 25.34% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 26.66 | 22.79 | 33.73 | 93.11 | 109.00 | 135.31 | 134.51 | 156.21 | 74.41 | 85.24 | 65.15 | 60.92 | 79.65 | 96.76 | 80.50 | 80.96 | 126.94 | 68.41 | 132.42 | 145.65 | 80.07 | 68.49 |
| 净利润 | 10.57 | -15.91 | 78.08 | 128.99 | 8.61 | 62.72 | 61.68 | 44.04 | 119.20 | 44.42 | 39.20 | 23.94 | 62.20 | 98.43 | 70.67 | 130.49 | 145.19 | 3.65 | 171.17 | 182.54 | 95.06 | -55.75 |
| 经营活动现金流量 | 21.61 | 26.30 | 65.72 | 33.92 | 108.22 | 123.83 | 100.22 | 116.54 | 79.89 | 125.38 | 103.76 | 64.51 | 109.22 | 134.40 | 102.53 | 141.09 | 190.95 | 130.06 | 214.68 | 164.72 | 57.93 | 92.88 |
| 投资活动现金流量 | -29.08 | -131.56 | -18.34 | 31.56 | -34.97 | -28.90 | -68.05 | -31.48 | -3.74 | -47.58 | -32.10 | 26.79 | 43.14 | -26.29 | -94.43 | -165.55 | -49.60 | -140.83 | -77.34 | -137.41 | -22.57 | -158.12 |
| 筹资活动现金流量 | -13.61 | 100.89 | -55.22 | -16.38 | -54.41 | -69.04 | -32.67 | -59.90 | -152.42 | -53.87 | -90.44 | -100.06 | -131.60 | -88.61 | -28.32 | 25.93 | -91.19 | -48.10 | -70.32 | -19.22 | -93.11 | -12.19 |
| 净现金流量 | -21.01 | -3.87 | -9.68 | 49.43 | 15.89 | 26.31 | -0.80 | 21.70 | -81.80 | 10.83 | -20.09 | -4.19 | 18.71 | 19.67 | -17.69 | 0.14 | 46.06 | -58.64 | 64.09 | 13.72 | -52.45 | -77.99 |
右侧两列为报告期累计口径同比(左:去年同期同一期次,右:最近一期季报,年报期次已在左侧列展示);周转率类指标为报告期累计值,未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD